![Jill Milne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jill Milne
Director/Board Member at
BIOCRYST PHARMACEUTICALS, INC.
Net worth: 286 803 $ as of 31/07/2026
Profile
Jill C.
Milne was the founder of Astria Therapeutics, Inc., founded in 2008, where the titles held included President, Chief Executive Officer & Director from 2019 to 2026.
Dr. Milne currently serves as a Director at BioCryst Pharmaceuticals, Inc., starting in 2026.
Former jobs include Head-Enzyme Target Group at Pfizer Inc., Head-Discovery Biology at Sirtris Pharmaceuticals, Inc. from 2004 to 2008, Principal at Polaris Growth Management LLC, and Head-Worldwide Drug Pfinder Program at Pfizer (St. Louis) from 1998 to 2004.
Education includes a doctorate from Harvard University and an undergraduate degree from Wellesley College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/06/2026 | 31,938 ( 0.01% ) | 286 803 $ | 31/07/2026 |
Jill Milne active positions
| Companies | Position | Start |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Director/Board Member | 23/01/2026 |
Former positions of Jill Milne
| Companies | Position | End |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Chief Executive Officer | 23/01/2026 |
Sirtris Pharmaceuticals, Inc.
 Sirtris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs and pharmaceuticals | Corporate Officer/Principal | 01/01/2008 |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Corporate Officer/Principal | 01/01/2004 |
| PFIZER INC. | Corporate Officer/Principal | - |
Polaris Growth Management LLC
 Polaris Growth Management LLC Investment ManagersFinance Polaris Partners invests primarily in companies in the consumer technology, digital media/entertainment, e-Commerce, network hardware, software and semiconductors sectors. They invest in seed, early-stage and high growth, middle-market companies. The firm's early-stage investments focus on information technology and life sciences companies. Within the information technology sector, Polaris looks for companies that are developing Internet and broadband infrastructure, enterprise software products, e-Commerce products/services, digital media/entertainment, consumer software, network hardware and network software. In the life sciences sector, the firm looks for companies that are developing medical devices, pharmaceuticals, genomics, proteomics, drug delivery, medical services and consumer products and services. Polaris' private equity efforts focus on high-growth, middle-market companies in industries including technology, healthcare, digital media, consumer products and services and business services. Polaris serves as the lead or co-lead investor in the vast majority of their portfolio companies. The firm participates in minority growth equity investments, recapitalizations with liquidity and LBOs. | Corporate Officer/Principal | - |
Training of Jill Milne
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
67
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Sirtris Pharmaceuticals, Inc.
Sirtris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs and pharmaceuticals | Health Technology |
Astria Therapeutics, Inc.
 Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
Polaris Growth Management LLC
Polaris Growth Management LLC Investment ManagersFinance Polaris Partners invests primarily in companies in the consumer technology, digital media/entertainment, e-Commerce, network hardware, software and semiconductors sectors. They invest in seed, early-stage and high growth, middle-market companies. The firm's early-stage investments focus on information technology and life sciences companies. Within the information technology sector, Polaris looks for companies that are developing Internet and broadband infrastructure, enterprise software products, e-Commerce products/services, digital media/entertainment, consumer software, network hardware and network software. In the life sciences sector, the firm looks for companies that are developing medical devices, pharmaceuticals, genomics, proteomics, drug delivery, medical services and consumer products and services. Polaris' private equity efforts focus on high-growth, middle-market companies in industries including technology, healthcare, digital media, consumer products and services and business services. Polaris serves as the lead or co-lead investor in the vast majority of their portfolio companies. The firm participates in minority growth equity investments, recapitalizations with liquidity and LBOs. | Finance |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wellesley College
 Wellesley College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
- Stock Market
- Insiders
- Jill Milne
